Search
for
Sort by
Research 61–90 of 1000+
- Drug Repurposing in Dermatology: Molecular Biology and Omics Approach
- Treatment of Alopecia Areata and Its Numerous Possibilities: A Literature Review
- Comparative characteristics of the effectiveness of drugs for the treatment of alopecia areata in childhood
- Alopecia: Updated management
- 41949 Raman spectroscopy of alopecia drugs to assess their potential for laser-assisted drug delivery
- New Treatment Strategies in Management of Alopecia Areata: Review Article
- 66-Year-Old Female with Itchy Scalp and Hair Loss
- 616 Updates in therapeutics for pediatric alopecia areata: A systematic review with evidence-based analysis
- Effect of tofacitinib on the expression of noggin/BMP-4 and hair growth stimulation in mice
- Tofacitinib Loaded Squalenyl Nanoparticles for Targeted Follicular Delivery in Inflammatory Skin Diseases
- Peripheral neuropathy associated with tofacitinib use in alopecia universalis
- Role of janus kinase inhibitors in the treatment of alopecia areata
- Emerging Topical and Systemic JAK Inhibitors in Dermatology
- Bletilla striata polysaccharide-based dissolving microneedle patch integrated with nanoparticles for promoting hair regrowth
- In Silico Structure-Based Drug Design Approach To Evaluate Quercetin And Kaempferol As Dual Inhibitors Of Jak3 Kinase And 5-Alpha Reductase Type II with ADMET Profiling
- Evolving treatment paradigms in dermatology: Insights from emerging and repurposed therapies
- Kaempferol enhances hair growth by regulating JAK3/STAT6 and TGF-β/Smad signaling in human dermal papilla cells and a C57BL/6 mousemodel
- Alopecia areata treated using CO2 fractional laser with different parameters
- The Triumph of JAK Inhibitors for the Treatment of Alopecia Areata
- Alopecia areata mit gutem Ansprechen auf Tofacitinib
- Tofacitinib (Selective Janus Kinase Inhibitor 1 and 3): A promising therapy for the treatment of alopecia areata: A case report of six patients
- Successful Treatment of Refractory Alopecia Areata Universalis and Psoriatic Arthritis, But Not of Plaque Psoriasis with Tofacitinib in a Young Woman
- An urticarial drug eruption caused by tofacitinib for alopecia universalis
- In Silico Structure-Based Drug Design Approach To Evaluate Quercetin And Kaempferol As Dual Inhibitors Of Jak3 Kinase And 5-Alpha Reductase Type II with ADMET Profiling
- Trachyonychia secondary to pediatric alopecia areata responding to oral tofacitinib therapy: a case report and review of literature
- Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition
- Overcoming hurdles: Side effects with old drugs and achieving success with novel drug in alopecia areata
- Reporting on Adverse Clinical Events
- Sequential small-molecule therapy for lymphocytic cicatricial alopecia: A multicenter prospective cohort pilot study
- Rebound effect associated with JAK inhibitor use in the treatment of alopecia areata